Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.

MLA

Cao, Yuze, et al. “Construction of an MiRNA-Regulated Drug-Pathway Network Reveals Drug Repurposing Candidates for Myasthenia Gravis.” International Journal of Molecular Medicine, vol. 39, no. 2, Feb. 2017, pp. 268–78. EBSCOhost, https://doi.org/10.3892/ijmm.2017.2853.

APA

Cao, Y., Lu, X., Wang, J., Zhang, H., Liu, Z., Xu, S., Wang, T., Ning, S., Xiao, B., & Wang, L. (2017). Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis. International Journal of Molecular Medicine, 39(2), 268–278. https://doi.org/10.3892/ijmm.2017.2853

Chicago

Cao, Yuze, Xiaoyan Lu, Jianjian Wang, Huixue Zhang, Zhaojun Liu, Si Xu, Tianfeng Wang, Shangwei Ning, Bo Xiao, and Lihua Wang. 2017. “Construction of an MiRNA-Regulated Drug-Pathway Network Reveals Drug Repurposing Candidates for Myasthenia Gravis.” International Journal of Molecular Medicine 39 (2): 268–78. doi:10.3892/ijmm.2017.2853.